Browse > Article
http://dx.doi.org/10.6114/jkood.2016.29.3.159

Effect of Armeniacae Amarum Semen on Expression of Bax and Bcl-2 mRNA and Caspase-3 Activity of Human DU145 Prostate Cancer Cells  

Lee, Do-Kyung (Department of Anatomy-Pointology, College of Korean Medicine, Gachon University)
Kim, Youn-Sub (Department of Anatomy-Pointology, College of Korean Medicine, Gachon University)
Kim, Do-Hoon (2Department of Korean Medical Classics & History, College of Korean Medicine, Gachon University)
Publication Information
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology / v.29, no.3, 2016 , pp. 159-167 More about this Journal
Abstract
Prostate cancer is one of the most common non-skin cancers in men. Armeniacae Amarum Semen has traditionally been used for the treatment of inflammation diseases, leprosy, leucoderma, and tumors. Apoptosis, which is also known as programmed cell death, is an important mechanism in cancer treatment.Objectives : We observed whether an aqueous extract of Armeniacae Amarum Semen induces apoptotic cell death in human DU145 prostate cancer cells.Methods : We treated DU145 cells with Armeniacae Amarum Semen extract and investigated characteristics of apoptosis. And investigated whether treated with Armeniacae Amarum Semen extract increased Bax mRNA expression, Bcl-2 mRNA expression, caspase-3 enzyme activity and their protein level.Results : We have shown that Armeniacae Amarum Semen extract can induce apoptotic cell death in human DU145 prostate cancer cells by caspase-3 activation through the down-regulation on Bcl-2 expression and the up-regulation on Bax expression.Conclusions : It can be expected that an aqueous extract of Armeniacae Amarum Semen may offer a valuable means for the treatment of prostate cancers.
Keywords
Armeniacae Amarum Semen; Prostate cancer; Apoptosis; Bcl-2; Bax; Caspase-3;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999; 49:8-31.   DOI
2 Pak JU, Moon SJ, Moon K, Won JH. J Kor Orient Oncol. 1999;5:137-50.
3 Hwang DR, Kang YS, Kim SS, Kim DH, Shin MK, Song HJ. Studies on the Allergic asthma effect of Semen Armeniaceae Amarum. Kor J Herbol. 2003;18:201-8.
4 Fukuta T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol Pharm Bull. 2003;26:271-3.   DOI
5 Shim BS, Park JK, Choi SH. J Kor Orient Oncol. 2000;6:19-28.
6 Ellison NM, Byar DP, Newell GR. Special report on Laetrile: the NCI Laetrile Review. Results of the National Cancer Institute's retrospective Laetrile analysis. New Engl J Med. 1978;299:549-52.   DOI
7 Wyllie AH, Kerr JF, Currie AR. Cell death: the significance ofapoptosis. Int Rev Cytol. 1980;68:251-306.   DOI
8 Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-19.   DOI
9 Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.   DOI
10 Nagata S. Apoptosis by death factor. Cell. 1997;88:355-65.   DOI
11 Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U.S.A. 2002;99:6252-6.   DOI
12 Thompson CB. Apoptosis in the pathogenesis and treatment of diseases. Science. 1995;267: 1456-62.   DOI
13 Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485-95.   DOI
14 Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78:539-42.   DOI
15 Steller H. Mechanisms and genes of cellular suicide. Science. 1995;267:1445-9.   DOI
16 Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.   DOI
17 Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair or apoptosis? Cancer Invest. 1992; 10:229-40.   DOI
18 Dive C, Hickman JA. Drug-target interactions; only the first step in the commitment to a programmed cell death? Br J Cancer. 1991;64:192-6.   DOI
19 Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells. 1990;2:275-80.
20 Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-26.   DOI
21 Tsujimoto Y, Croce CM. Analysis and structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA. 1986; 83:5314-8.   DOI
22 Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson MM, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Path. 1993;143:390-400.
23 McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, et al. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen-independent prostate cancer. J Urol. 1997;157:569-74.   DOI
24 McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992;52:6940-4.
25 Gleave ME, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, et al. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. Clin Cancer Res. 1999;5:2891-8.
26 Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, et al. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis expression of Bcl-2 family members, and caspase activation. Prostate. 2000;42:260-73.   DOI
27 Miyake H, Monia BP, Gleave ME. Inhibition of progression to androgen-induced by combine adjuvant treatment with antisense BCL-xL and antisense Bcl-2 oligonucleotide plus Taxol after castration in the shionogi tumor model. Int J Cancer. 2000;86:855-62.   DOI
28 Du C, Fang M, Li Y, Li L, Wang X. Smac, amitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 2000;102: 33-42.   DOI
29 Verhagen AM, Ekert PG, Pakusch M. Silke J, Connolly LM, Reid GE, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 2000;102:55-66.   DOI
30 Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Gene Therapy. 2001;8:1363-71.   DOI
31 Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, et al. Immunohistochemistry of caspase-3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res. 1998;18:4347-53.